PA
Profund Advisors Portfolio holdings
AUM
$2.78B
1-Year Return
29.53%
This Quarter Return
+15.99%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$2.57B
AUM Growth
+$240M
(+10%)
Cap. Flow
+$2.26M
Cap. Flow
% of AUM
0.09%
Top 10 Holdings %
Top 10 Hldgs %
34.11%
Holding
1,211
New
84
Increased
525
Reduced
539
Closed
63
Top Buys
| 1 |
NVIDIA
NVDA
|
$23.5M |
| 2 |
Linde
LIN
|
$16.4M |
| 3 |
Broadcom
AVGO
|
$3.16M |
| 4 |
Advanced Micro Devices
AMD
|
$2.67M |
| 5 |
Qualcomm
QCOM
|
$1.54M |
Top Sells
| 1 |
Exxon Mobil
XOM
|
$6.7M |
| 2 |
Microsoft
MSFT
|
$5.59M |
| 3 |
Chevron
CVX
|
$4.56M |
| 4 |
Meta Platforms (Facebook)
META
|
$4.45M |
| 5 |
Viking Therapeutics
VKTX
|
$3.77M |
Sector Composition
| 1 | Technology | 42.5% |
| 2 | Healthcare | 12.67% |
| 3 | Consumer Discretionary | 11.07% |
| 4 | Communication Services | 9.14% |
| 5 | Financials | 5.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Roblox
RBLX
$88.5B
| $1.51M | 0.06% |
39,674
+3,927
| +11% | +$150K |
|
227
Vericel Corp
VCEL
$1.72B
| $1.5M | 0.06% |
28,845
+9,299
| +48% | +$484K |
|
228
Roivant Sciences
ROIV
$8.82B
| $1.5M | 0.06% |
142,347
-1,768
| -1% | -$18.6K |
|
229
Gold Fields
GFI
$30.8B
| $1.5M | 0.06% |
94,347
+7,776
| +9% | +$124K |
|
|
CERE
230
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $1.49M | 0.06% |
35,234
+11,209
| +47% | +$474K |
|
231
Revolution Medicines
RVMD
$7.57B
| $1.49M | 0.06% |
46,114
-14,993
| -25% | -$483K |
|
232
Rhythm Pharmaceuticals
RYTM
$6.78B
| $1.49M | 0.06% |
34,281
+13,790
| +67% | +$598K |
|
233
New Oriental
EDU
$7.98B
| $1.48M | 0.06% |
17,062
-3,808
| -18% | -$331K |
|
234
Incyte
INCY
$16.9B
| $1.48M | 0.06% |
25,985
-3,096
| -11% | -$176K |
|
|
JNPR
235
DELISTED
Juniper Networks
JNPR
| $1.48M | 0.06% |
39,840
-2,190
| -5% | -$81.2K |
|
236
Fiserv
FI
$73.4B
| $1.48M | 0.06% |
9,235
+1,164
| +14% | +$186K |
|
237
Blackstone
BX
$133B
| $1.47M | 0.06% |
11,209
+1,918
| +21% | +$252K |
|
238
Match Group
MTCH
$9.18B
| $1.46M | 0.06% |
40,365
+3,031
| +8% | +$110K |
|
239
Vaxcyte
PCVX
$4.29B
| $1.46M | 0.06% |
21,429
-5,851
| -21% | -$400K |
|
240
Philip Morris
PM
$251B
| $1.46M | 0.06% |
15,950
-1,070
| -6% | -$98K |
|
241
Zoom
ZM
$25B
| $1.46M | 0.06% |
22,313
+2,881
| +15% | +$188K |
|
242
Immunovant
IMVT
$2.99B
| $1.45M | 0.06% |
45,004
+7,544
| +20% | +$244K |
|
243
Sarepta Therapeutics
SRPT
$1.96B
| $1.45M | 0.06% |
11,165
-5,112
| -31% | -$662K |
|
|
ALPN
244
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $1.44M | 0.06% |
36,372
+22,934
| +171% | +$909K |
|
245
Insmed
INSM
$30.7B
| $1.44M | 0.06% |
52,943
-1,084
| -2% | -$29.4K |
|
246
Okta
OKTA
$16.1B
| $1.43M | 0.06% |
13,642
-1,606
| -11% | -$168K |
|
247
Natera
NTRA
$23.1B
| $1.43M | 0.06% |
15,594
-8,768
| -36% | -$802K |
|
248
American Tower
AMT
$92.9B
| $1.43M | 0.06% |
7,214
-730
| -9% | -$144K |
|
249
Li Auto
LI
$24B
| $1.42M | 0.06% |
46,826
+33,171
| +243% | +$1M |
|
|
SWTX
250
DELISTED
SpringWorks Therapeutics
SWTX
| $1.41M | 0.06% |
28,686
+4,247
| +17% | +$209K |
|